Ausgabe 5/2011
Inhalt (10 Artikel)
Editorial
Pharmaceutical patents, R&D incentives and access to new drugs: new ways of progress at the crossroad
Fernando Antoñanzas, Carmelo Juárez-Castelló, Roberto Rodríguez-Ibeas
Open Access
Original Paper
Largely ignored: the impact of the threshold value for a QALY on the importance of a transferability factor
Pepijn Vemer, Maureen P. M. H. Rutten-van Mölken
Original Paper
Discrimination in waiting times by insurance type and financial soundness of German acute care hospitals
Christoph Schwierz, Achim Wübker, Ansgar Wübker, Björn A. Kuchinke
Original Paper
Hospital’s activity-based financing system and manager: physician interaction
David Crainich, Hervé Leleu, Ana Mauleon
Original Paper
Contractual conditions, working conditions and their impact on health and well-being
Silvana Robone, Andrew M. Jones, Nigel Rice
Original Paper
Comparing top-down and bottom-up costing approaches for economic evaluation within social welfare
Tina M. Olsson
Open Access
Original Paper
Cost of low back pain in Switzerland in 2005
Simon Wieser, Bruno Horisberger, Sara Schmidhauser, Claudia Eisenring, Urs Brügger, Andreas Ruckstuhl, Jürg Dietrich, Anne F. Mannion, Achim Elfering, Özgür Tamcan, Urs Müller
Original Paper
Ageing and health care expenditure in EU-15
Mickael Bech, Terkel Christiansen, Ehsan Khoman, Jørgen Lauridsen, Martin Weale
Open Access
Original paper
Atrial fibrillation: the cost of illness in Sweden
Lisa Ericson, Lennart Bergfeldt, Ingela Björholt
Original Paper
Cost-effectiveness of cognitive-behavioral group therapy for dysfunctional fear of progression in cancer patients
C. Sabariego, M. Brach, P. Herschbach, P. Berg, G. Stucki